Vitamin D regulates macrophage cholesterol metabolism in diabetes

[1]  P. Toth.  1,25(OH)2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus , 2010 .

[2]  S. Watkins,et al.  Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis , 2009, Nature Medicine.

[3]  K. Schechtman,et al.  1,25(OH)2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus , 2009, Circulation.

[4]  M. Chonchol,et al.  25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. , 2009, Atherosclerosis.

[5]  B. Astor,et al.  25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population , 2008 .

[6]  D. Whellan,et al.  Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). , 2008, The American journal of cardiology.

[7]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[8]  G. McMahon,et al.  Intensive glycemic control in the ACCORD and ADVANCE trials. , 2008, The New England journal of medicine.

[9]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[10]  J. Sugden,et al.  Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[11]  H. Lentzner,et al.  Multiple causes of death in old age. , 2008, Aging trends.

[12]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[13]  M. Chonchol,et al.  Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  J. Leahy.  Mortality Trends in Men and Women with Diabetes, 1971 to 2000 , 2008 .

[15]  K. Narayan,et al.  Mortality Trends in Men and Women with Diabetes, 1971 to 2000 , 2007, Annals of Internal Medicine.

[16]  C. Mathieu,et al.  Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. , 2007, Diabetes research and clinical practice.

[17]  Keith C. Norris,et al.  Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. , 2007, Archives of internal medicine.

[18]  A. Tall,et al.  The Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis , 2007, Circulation research.

[19]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[20]  Shobha Ghosh,et al.  Stable overexpression of human macrophage cholesteryl ester hydrolase results in enhanced free cholesterol efflux from human THP1 macrophages. , 2007, American journal of physiology. Cell physiology.

[21]  C. Lovly,et al.  The role of NF-κB-1 and NF-κB-2-mediated resistance to apoptosis in lymphomas , 2006 .

[22]  D. Accili,et al.  Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. , 2006, Cell metabolism.

[23]  A. Tedgui,et al.  Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.

[24]  G. Targher,et al.  Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. , 2006, Diabetes care.

[25]  S. Hazen,et al.  A CD36‐dependent signaling cascade is necessary for macrophage foam cell formation , 2006, Cell metabolism.

[26]  C. Lovly,et al.  The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Targher,et al.  Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. , 2006, Diabetes care.

[28]  Yibin Wang,et al.  Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor , 2005, The Journal of cell biology.

[29]  R. Austin,et al.  Activation of the Unfolded Protein Response Occurs at All Stages of Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice , 2005, Circulation.

[30]  D. Rader,et al.  Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? , 2005, Cell metabolism.

[31]  J. Powell,et al.  Vitamin D, shedding light on the development of disease in peripheral arteries. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[32]  G. Sumara,et al.  “Jnking” atherosclerosis , 2004, Science.

[33]  M. Holick,et al.  Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. , 2004, The American journal of clinical nutrition.

[34]  G. Hitman,et al.  Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? , 2002, QJM : monthly journal of the Association of Physicians.

[35]  A. Tall,et al.  Regulation and mechanisms of macrophage cholesterol efflux. , 2002, The Journal of clinical investigation.

[36]  J. Oram.  ATP-binding cassette transporter A1 and cholesterol trafficking , 2002, Current opinion in lipidology.

[37]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[38]  C. Mathieu,et al.  The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. , 2002, Trends in molecular medicine.

[39]  C. Glass,et al.  Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein , 1998 .

[40]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[41]  R. Evans,et al.  PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. , 1998, Cell.

[42]  Yukiko Kurihara,et al.  A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.

[43]  S. Otani,et al.  Effect of 1,25‐dihydroxyvitamin D3 on induction of scavenger receptor and differentiation of 12‐O‐tetradecanoylphorbol‐13‐acetate‐treated THP‐1 human monocyte like cells , 1995, Journal of cellular physiology.

[44]  S. Yamashita,et al.  Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. , 1995, The Journal of clinical investigation.

[45]  H. Lodish,et al.  Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.

[46]  末松 雄二.  Effect of 1,25-dihydroxyvitamin D[3] on induction of scavenger receptor and differentiation of 12-O-tetradecanoylphorbol-13-acetate-treated THP-1 human monocyte like cells , 1994 .

[47]  L. Stanton,et al.  CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.

[48]  D. McNamara,et al.  Lipoprotein receptors of HL-60 macrophages. Effect of differentiation with tetramyristic phorbol acetate and 1,25-dihydroxyvitamin D3. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[49]  D. McCarron,et al.  1,25-Dihydroxyvitamin D3-induced alterations of lipid metabolism in human monocyte-macrophages. , 1989, The American journal of physiology.

[50]  T. Kodama,et al.  Purification and characterization of a bovine acetyl low density lipoprotein receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[51]  H. DeLuca,et al.  Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. , 1984, Cancer research.